Literature DB >> 36147785

Serum level of prophylactic antibiotics in cardiac surgery and its implication on surgical site infection (SSI).

Turki B Albacker1, Hussain Alqattan1, Saeed A Alqahtani2, Sultan Alamro1, Norah Alsuwaidan1, Alhanouf Alaloola1, Ahmed Eldemerdash1, Bakir Bakir1.   

Abstract

BACKGROUND: Surgical site infection in cardiac surgery is still common despite applying preoperative antibiotic prophylaxis as per guidelines. Therefore, the aim of our study was to assess the relationship between perioperative antibiotics serum levels and the incidence of surgical site infection.
METHODS: This is a prospective study that included all adult patients who underwent elective coronary artery bypass grafting between June and December 2018. The serum antibiotics levels were measured at 4 different time points. The patients were divided into two groups: The group who developed surgical site infection and the group who did not develop surgical site infection. The serum antibiotics levels were compared between the two groups.
RESULTS: Eighty-seven consecutive patients were enrolled in the study. The overall rate of infection was 17.95% (14/78 patients). High pre-operative HbA1C levels were associated with a higher rate of SSI (SSI 8.46 ± 2.23 vs no SSI 7.28 ± 1.82, P = 0.04). Patients who developed surgical site infection had longer intervals between administration of prophylactic antibiotics and different parts of the procedure than those who did not develop infection T2 (SSI 3.09 ± 1.12 vs no SSI 2.32 ± 0.98, P = 0.004), T3 (SSI 5.74 ± 1.69 vs no SSI 4.68 ± 1.83, P = 0.024) and T4 (SSI 7.35 ± 1.97 vs no SSI 6.01 ± 2.11, P = 0.015).
CONCLUSION: Prolonging different parts of cardiac surgery procedures could lead to higher risk of infection and better timing of intra-operative re-dosing of prophylactic antibiotics could be guided by measuring intra-operative serum concentrations of these antibiotics. AJCD
Copyright © 2022.

Entities:  

Keywords:  Coronary artery bypass grafting; cefuroxime; prophylactic antibiotics; serum antibiotic concentration; surgical site infection

Year:  2022        PMID: 36147785      PMCID: PMC9490157     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  9 in total

1.  Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery.

Authors:  Erika K Fellinger; Bruce J Leavitt; James C Hebert
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

2.  The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery.

Authors:  C S Hollenbeak; D M Murphy; S Koenig; R S Woodward; W C Dunagan; V J Fraser
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

3.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Joseph P Ornato
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

4.  Compliance with surgical antibiotic prophylaxis at an Australian teaching hospital.

Authors:  N Deborah Friedman; Kaylene Styles; Ann M Gray; Jillian Low; Eugene Athan
Journal:  Am J Infect Control       Date:  2012-06-30       Impact factor: 2.918

5.  Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial.

Authors:  Patrique Segers; Ron G H Speekenbrink; Dirk T Ubbink; Marc L van Ogtrop; Bas A de Mol
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

Review 6.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.

Authors:  Dale W Bratzler; Peter M Houck
Journal:  Am J Surg       Date:  2005-04       Impact factor: 2.565

7.  The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration.

Authors:  Fred H Edwards; Richard M Engelman; Peter Houck; David M Shahian; Charles R Bridges
Journal:  Ann Thorac Surg       Date:  2006-01       Impact factor: 4.330

Review 8.  The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice.

Authors:  Richard Engelman; David Shahian; Richard Shemin; T Sloane Guy; Dale Bratzler; Fred Edwards; Marshall Jacobs; Hiran Fernando; Charles Bridges
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

9.  Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.

Authors:  Megan H Nguyen; Samantha J Eells; Jennifer Tan; Corinne T Sheth; Bassam Omari; Margarita Flores; Jeffrey Wang; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.